Kazia Therapeutics
KZIA
9 hedge funds and large institutions have $400K invested in Kazia Therapeutics in 2018 Q3 according to their latest regulatory filings, with 4 funds opening new positions, 1 increasing their positions, 2 reducing their positions, and 1 closing their positions.
300% more first-time investments, than exits
New positions opened: 4 | Existing positions closed: 1
50% more funds holding
Funds holding: 6 → 9 (+3)
27% more capital invested
Capital invested by funds: $314K → $400K (+$86K)
0.87% more ownership
Funds ownership: 0.8% → 1.67% (+0.87%)
50% less repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 2
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
TW
Transform Wealth
Greenwood Village,
Colorado
|
+$361K |
| 2 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$37.7K |
| 3 |
Morgan Stanley
New York
|
+$15K |
| 4 |
SPIA
Steward Partners Investment Advisory
New York
|
+$1.87K |
| 5 |
Fifth Third Bancorp
Cincinnati,
Ohio
|
+$170 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Acadian Asset Management
Boston,
Massachusetts
|
-$19.4K |
| 2 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
-$4K |
| 3 |
UBS Group
Zurich,
Switzerland
|
-$1.36K |
KZIA Hedge Fund Activity: Q3 2018 in Review
9 of the 4,391 institutional investors tracked by Wall St. Rank reported a position in Kazia Therapeutics (KZIA) for Q3 2018, worth a combined $400K — up 27% from $314K a quarter earlier.
Buyers outnumbered sellers: 4 funds opened new KZIA positions and 1 closed out — a net gain of 3 holders — while 1 added to existing stakes and 2 trimmed.
The largest buyer was Transform Wealth, opening a new position worth an estimated $361K. The largest seller was Acadian Asset Management, cutting an estimated $19.4K.
- 9 institutional investors held Kazia Therapeutics (KZIA) as of Q3 2018, up from 6 in Q2 2018.
- Funds reported $400K of Kazia Therapeutics stock for Q3 2018, up 27% quarter-over-quarter.
- 4 funds opened new Kazia Therapeutics positions in Q3 2018 and 1 closed out, a net change of +3 holders.
- The largest Kazia Therapeutics buyer in Q3 2018 was Transform Wealth, an estimated $361K added.
- The largest Kazia Therapeutics seller in Q3 2018 was Acadian Asset Management, an estimated $19.4K sold.
Based on aggregated 13F filings for Q3 2018.